Increase access and address inequalities
Canopie can be provided to all new parents as a prevention and early intervention approach. This supports the hundreds of thousands of mothers with mild to moderate depression who currently wait months to receive treatment.
CURRENT SERVICES CAN NOT ADDRESS THE NEED
Anxiety and depression are the most common complications of pregnancy and childbirth but specialist perinatal mental health services can only currently support the most severe cases.
What is Canopie?
Canopie is a low cost, digital platform that creates personalised, evidence-based programs to prevent and address symptoms of anxiety and depression in expecting and new mothers. It can be given to every single new parent as a way to normalise struggles in this period and tackle barriers to care.
Built on extensive
Canopie has been co-created with input from hundreds of new parents, dozens of health professionals and academics, and is based on over 50 RCTs.
We adapted clinically validated therapeutic techniques and programs to make them more approachable, engaging, and human.
Audio and video
Programs are made up of soothing audio modules and animated videos, with read along text.
Accessible to diverse audiences
Pathways for caregivers who identify as expecting, mother, father, or parent, with all content in plain English for reading age 11.
Available in multiple languages
All of Canopie's content is available in English and Spanish with more languages coming soon.
Canopie has been reviewed by ORCHA and received a score of 73% (over the quality benchmark of 65%).
The benefits of working together
Low-cost public health approach which can increase access and prevent escalation of problems
Immediate improvement in mental health for new mothers within two weeks
Reduces demand on midwives, health visitors and GPs who currently feel the pressure
Reduces downstream costs e.g. for adult mental health services, GP appointments and hospitals visits
Flexible pricing model to fit within any budget or scope
Results from our initial randomized controlled trial indicates significant clinical improvement after only 2 weeks of engagement. 79.3% of participants with possible symptoms of depression had a clinically significant change in their mood